AUGX
AUG Therapeutics
Phase 3
Estimated
AVTX-803 (L-Fucose)
Leukocyte Adhesion Deficiency
T-minus 56 days
Nov 30, 2026
ClinicalTrials.gov
verified 3mo ago
Countdown card →